Literature DB >> 22995752

Limited economic evidence of carotid artery stenosis diagnosis and treatment: a systematic review.

A U Shenoy1, M Aljutaili, B Stollenwerk.   

Abstract

UNLABELLED: The objective of this article is to assess the availability and validity of economic evaluations of carotid artery stenosis (CS) diagnosis and treatment.
DESIGN: Systematic review of economic evaluations of the diagnosis and treatment of CS.
METHODS: Systematic review of full economic evaluations published in Medline and Google Scholar up until 28 February 2012. Based on economic checklists (Evers and Philips), the identified studies were classified as high, medium, or low quality.
RESULTS: Twenty-three evaluations were identified. The study quality ranged from 26% to 84% of all achievable points (Evers). Seven studies were of high, eight of medium and eight of low quality. No comparison was made between carotid angioplasty and stenting (CAS) and best medical treatment (BMT). For subjects with severe stenosis, comparisons of carotid endarterectomy (CEA) and BMT were also missing. Three of five studies dealing with pre-operative imaging found that duplex Doppler ultrasound (US) was cost-effective compared with carotid angiogram (AG).
CONCLUSIONS: There is a huge lack of high-quality studies and of studies that confirm published results. Also, for a given study quality, the most cost-effective treatment strategy is still unknown in some cases ('CAS' vs. 'BMT', 'US combined with magnetic resonance angiography supplemented with AG' vs. 'US combined with computer tomography angiography').
Copyright © 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22995752     DOI: 10.1016/j.ejvs.2012.08.010

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  7 in total

1.  Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach.

Authors:  Björn Stollenwerk; Thomas Welchowski; Matthias Vogl; Stephanie Stock
Journal:  Eur J Health Econ       Date:  2015-02-04

2.  Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation.

Authors:  Björn Stollenwerk; Afschin Gandjour; Markus Lüngen; Uwe Siebert
Journal:  Eur J Health Econ       Date:  2012-12-30

3.  Risk Factors for Carotid Artery Stenosis in Chinese Patients Undergoing Coronary Artery Bypass Graft Interventions.

Authors:  Yi Cheng; Junyi Gao; Jiong Wang; Shuang Wang; Jianjun Peng
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

4.  The association between health system development and the burden of cardiovascular disease: an analysis of WHO country profiles.

Authors:  Yanmei Liu; Koustuv Dalal; Björn Stollenwerk
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

5.  Breast cancer attributable costs in Germany: a top-down approach based on sickness funds data.

Authors:  Emil Victor Gruber; Stephanie Stock; Björn Stollenwerk
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

6.  The effectiveness of the cardiovascular disease prevention programme 'KardioPro' initiated by a German sickness fund: a time-to-event analysis of routine data.

Authors:  Sabine Witt; Reiner Leidl; Christian Becker; Rolf Holle; Michael Block; Johannes Brachmann; Sigmund Silber; Björn Stollenwerk
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

7.  Prevalence of carotid artery stenosis in ischaemic heart disease patients in Bangladesh.

Authors:  Dipannita Adhikary; Redoy Ranjan; Sabita Mandal; Mohammad Delwer Hossain Hawlader; Dipak Kumar Mitra; Asit Baran Adhikary
Journal:  SAGE Open Med       Date:  2019-02-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.